Sjs Investment Consulting Inc. Exelixis, Inc. Transaction History
Sjs Investment Consulting Inc.
- $534 Million
- Q3 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 54 shares of EXEL stock, worth $1,964. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54
Previous 54
-0.0%
Holding current value
$1,964
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EXEL
# of Institutions
503Shares Held
244MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.22 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$1.07 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$924 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$559 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$416 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...